Insiders / Baker Bros. Advisors LP

Baker Bros. Advisors LP

CIK 1263508personinsiderbeneficial ownerfund
Companies
13
First seen
Jan 5, 2026
Last activity
Jun 29, 2026

Companies

13View all →
CompanyRoleShares heldPeak heldTradesLatest
ACADIA Pharmaceuticals Inc · ACADDirector39,384,58739,384,5874—
Incyte Corp · INCYDirector28,205,36028,205,36012—
Denali Therapeutics Inc. · DNLIDirector3,422,3663,422,3664—
Madrigal Pharmaceuticals, Inc. · MDGLDirector1,948,8761,948,8764—
BeOne Medicines Ltd. · ONCDirector—161,5506—
Bicycle Therapeutics plc · BCYCDirector—10,018,6744—
Dbv Technologies S.A. · DBVTDirector—25,005,2404—
Kiniksa Pharmaceuticals International, plc · KNSADirector—2,744,8944—
Kymera Therapeutics, Inc. · KYMRDirector—6,0682—
Prelude Therapeutics Incorporated · PRLDDirector—20,105,9944—

All securities held

21 positions · latest reported per filing
CompanySecuritySharesAs of
ACADIA Pharmaceuticals IncCommon Stock39,384,587May 29, 2026
ACADIA Pharmaceuticals IncNon- Qualified Stock Option (right to buy)Derivative32,008May 29, 2026
BeOne Medicines Ltd.Ordinary Shares161,550Jun 11, 2026
Bicycle Therapeutics plcAmerican Depositary Shares10,018,674Jan 2, 2026
Bicycle Therapeutics plcShare Option (Right to Buy)Derivative38,000Jan 2, 2026
Dbv Technologies S.A.Second Pre-Funded WarrantDerivative25,005,240Jan 12, 2026
Denali Therapeutics Inc.Common Stock3,422,366Jun 3, 2026
Denali Therapeutics Inc.Non- Qualified Stock Option (right to buy)Derivative19,226Jun 3, 2026
Denali Therapeutics Inc.Non-Qualified Stock Option (right to buy)Derivative19,226Jun 3, 2026
Incyte CorpCommon Stock28,205,360Jun 8, 2026
Incyte CorpNon-Qualified Stock Options (right to buy)Derivative6,111Jun 8, 2026
Kiniksa Pharmaceuticals International, plcClass A Ordinary Shares2,744,894May 29, 2026
Kiniksa Pharmaceuticals International, plcNon- Qualified Share Option (right to buy)Derivative36,474May 29, 2026
Kymera Therapeutics, Inc.Non-Qualified Stock Option (right to buy)Derivative6,068Jun 24, 2026
Madrigal Pharmaceuticals, Inc.Common Stock1,948,876Jun 17, 2026
Madrigal Pharmaceuticals, Inc.Non-Qualified Stock Options (right to buy)Derivative1,532Jun 17, 2026
Prelude Therapeutics IncorporatedWarrants to purchase Common StockDerivative20,105,994Apr 21, 2026
Prelude Therapeutics IncorporatedNon-Qualified Stock Option (right to buy)Derivative38,000Jun 9, 2026
Replimune Group, Inc.Non-Qualified Stock Option (right to buy)uy)Derivative44,500Apr 1, 2026
TScan Therapeutics, Inc.Non- Qualified Stock Option (right to buy)Derivative67,000May 20, 2026
vTv Therapeutics Inc.Non-Qualified Stock Option (right to buy)Derivative6,000Jun 26, 2026

Activity

View all →
InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
May 8, 2026ExerciseINCY
Incyte Corp
Common Stock
$1.27M+15K
+0.05%
28,203,718
13.91% of shares
low
May 8, 2026ExerciseINCY
Incyte Corp
Common Stock
$1.27M+15K
+0.53%
2,833,039
1.40% of shares
low
May 22, 2026SellONC
BeOne Medicines Ltd.
Ordinary Shares
$65.6K-3K
-1.90%
142,570
<0.01% of shares
low
May 22, 2026SellONC
BeOne Medicines Ltd.
Ordinary Shares
$65.6K-3K
-1.90%
142,566
<0.01% of shares
low
May 22, 2026SellONC
BeOne Medicines Ltd.
Ordinary Shares
$65.4K-3K
-1.85%
145,326
<0.01% of shares
low
May 22, 2026SellONC
BeOne Medicines Ltd.
Ordinary Shares
$65.4K-3K
-1.85%
145,322
<0.01% of shares
low
Jun 17, 2026GrantMDGL
Madrigal Pharmaceuticals, Inc.
Common Stock
$0+908
+0.05%
1,948,876
8.44% of shares
low
Jun 17, 2026GrantMDGL
Madrigal Pharmaceuticals, Inc.
Common Stock
$0+908
+0.45%
203,721
0.88% of shares
low
Jun 11, 2026GrantONC
BeOne Medicines Ltd.
Ordinary Shares
$0+19K
+13.31%
161,550
0.01% of shares
low
Jun 11, 2026GrantONC
BeOne Medicines Ltd.
Ordinary Shares
$0+19K
+13.31%
161,546
0.01% of shares
low